Fig. 3From: Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosisCumulative medical costs of patients with ATTR-CM. a Inpatient and outpatient costs; b disease-related costs. ATTR-CM: Transthyretin amyloid cardiomyopathy, CV: CardiovascularBack to article page